183 related articles for article (PubMed ID: 22015269)
1. Design and synthesis of biologically active peptides: a 'tail' of amino acids can modulate activity of synthetic cyclic peptides.
Bryan A; Joseph L; Bennett JA; Jacobson HI; Andersen TT
Peptides; 2011 Dec; 32(12):2504-10. PubMed ID: 22015269
[TBL] [Abstract][Full Text] [Related]
2. Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein.
Joseph LC; Bennett JA; Kirschner KN; Shields GC; Hughes J; Lostritto N; Jacobson HI; Andersen TT
J Pept Sci; 2009 Apr; 15(4):319-25. PubMed ID: 19189271
[TBL] [Abstract][Full Text] [Related]
3. Development of a synthetic cyclized peptide derived from alpha-fetoprotein that prevents the growth of human breast cancer.
Mesfin FB; Andersen TT; Jacobson HI; Zhu S; Bennett JA
J Pept Res; 2001 Sep; 58(3):246-56. PubMed ID: 11576331
[TBL] [Abstract][Full Text] [Related]
4. Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization.
DeFreest LA; Mesfin FB; Joseph L; McLeod DJ; Stallmer A; Reddy S; Balulad SS; Jacobson HI; Andersen TT; Bennett JA
J Pept Res; 2004 May; 63(5):409-19. PubMed ID: 15140158
[TBL] [Abstract][Full Text] [Related]
5. AFPep: an anti-breast cancer peptide that is orally active.
Bennett JA; DeFreest L; Anaka I; Saadati H; Balulad S; Jacobson HI; Andersen TT
Breast Cancer Res Treat; 2006 Jul; 98(2):133-41. PubMed ID: 16538538
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, solution structure, and biological evaluation of urokinase type plasminogen activator (uPA)-derived receptor binding domain mimetics.
Schmiedeberg N; Schmitt M; Rölz C; Truffault V; Sukopp M; Bürgle M; Wilhelm OG; Schmalix W; Magdolen V; Kessler H
J Med Chem; 2002 Nov; 45(23):4984-94. PubMed ID: 12408709
[TBL] [Abstract][Full Text] [Related]
7. Alpha-fetoprotein-derived antiestrotrophic octapeptide.
Mesfin FB; Bennett JA; Jacobson HI; Zhu S; Andersen TT
Biochim Biophys Acta; 2000 Apr; 1501(1):33-43. PubMed ID: 10727847
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S.
Lee DL; Hodges RS
Biopolymers; 2003; 71(1):28-48. PubMed ID: 12712499
[TBL] [Abstract][Full Text] [Related]
9. Interaction of W-substituted analogs of cyclo-RRRWFW with bacterial lipopolysaccharides: the role of the aromatic cluster in antimicrobial activity.
Bagheri M; Keller S; Dathe M
Antimicrob Agents Chemother; 2011 Feb; 55(2):788-97. PubMed ID: 21098244
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural product.
Williams PD; Bock MG; Tung RD; Garsky VM; Perlow DS; Erb JM; Lundell GF; Gould NP; Whitter WL; Hoffman JB
J Med Chem; 1992 Oct; 35(21):3905-18. PubMed ID: 1331448
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: importance of the Phe/Arg relative conformation and the primary amino group for activity.
Matsoukas JM; Panagiotopoulos D; Keramida M; Mavromoustakos T; Yamdagni R; Wu Q; Moore GJ; Saifeddine M; Hollenberg MD
J Med Chem; 1996 Aug; 39(18):3585-91. PubMed ID: 8784457
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P.
Byk G; Halle D; Zeltser I; Bitan G; Selinger Z; Gilon C
J Med Chem; 1996 Aug; 39(16):3174-8. PubMed ID: 8759639
[TBL] [Abstract][Full Text] [Related]
13. Global optimization of conformational constraint on non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain.
Long YQ; Lung FD; Roller PP
Bioorg Med Chem; 2003 Sep; 11(18):3929-36. PubMed ID: 12927853
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship studies optimizing the antiproliferative activity of novel cyclic somatostatin analogues containing a restrained cyclic beta-amino acid.
Sukopp M; Schwab R; Marinelli L; Biron E; Heller M; Várkondi E; Pap A; Novellino E; Kéri G; Kessler H
J Med Chem; 2005 Apr; 48(8):2916-26. PubMed ID: 15828830
[TBL] [Abstract][Full Text] [Related]
15. Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S.
Lee DL; Powers JP; Pflegerl K; Vasil ML; Hancock RE; Hodges RS
J Pept Res; 2004 Feb; 63(2):69-84. PubMed ID: 15009528
[TBL] [Abstract][Full Text] [Related]
16. Potentiating effect of distant sites in non-phosphorylated cyclic peptide antagonists of the Grb2-SH2 domain.
Long YQ; Guo R; Luo JH; Yang D; Roller PP
Biochem Biophys Res Commun; 2003 Oct; 310(2):334-40. PubMed ID: 14521914
[TBL] [Abstract][Full Text] [Related]
17. Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity.
Komatsu Y; Tomizaki KY; Tsukamoto M; Kato T; Nishino N; Sato S; Yamori T; Tsuruo T; Furumai R; Yoshida M; Horinouchi S; Hayashi H
Cancer Res; 2001 Jun; 61(11):4459-66. PubMed ID: 11389076
[TBL] [Abstract][Full Text] [Related]
18. Amino acids that specify structure through hydrophobic clustering and histidine-aromatic interactions lead to biologically active peptidomimetics.
Graciani NR; Tsang KY; McCutchen SL; Kelly JW
Bioorg Med Chem; 1994 Sep; 2(9):999-1006. PubMed ID: 7712134
[TBL] [Abstract][Full Text] [Related]
19. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
[TBL] [Abstract][Full Text] [Related]
20. Cyclic peptide analysis of the biologically active loop region in the laminin alpha3 chain LG4 module demonstrates the importance of peptide conformation on biological activity.
Kato-Takagaki K; Suzuki N; Yokoyama F; Takaki S; Umezawa K; Higo J; Mochizuki M; Kikkawa Y; Oishi S; Utani A; Nomizu M
Biochemistry; 2007 Feb; 46(7):1952-60. PubMed ID: 17261031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
